International Society for the Study of Women's Sexual Health - ISSWSH Annual Meeting 2021
Enduring / On-Demand: Through March 7, 2022
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women's Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this enduring material for a maximum of 20.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Amedco LLC designates this enduring material for a maximum of 20.00 psychologist contact hours.
The following state boards accept courses from APA providers for Counselors: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MD, ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WI, WY
MI: No CE requirements
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (outstate held)*, OK, OR, SC, UT, WA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY
* If the activity is held live in the state of NY, then direct addictions board is required, ie: NAADAC. If the activity is held outside NY, is virtual, enduring or remote, it is considered "outstate" and this reciprocity applies.
Texas Physical Therapy Association (TX PT)
This activity has been approved by the Texas Board of Physical Therapy Examiners for 20.0 CCUs for PTs and PTAs.
Sponsor Name: International Society for the Study of Women’s Sexual Health
Course Approval Number: 48243.
States with reciprocity with Texas Physical Therapy Association: AL, AK, AZ, CT, DE, GA, HI, ID, IN, IA, KS, KY, LA, ME, MA, MI, MN, MI, MS, NE, NH, NC, ND, OR, RI, SC, SD, TN, UT, VT, VA, WA, WI, WY-updated 02/18
New York Board for Psychology (NY PSY)
Amedco is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0031. 20 hours enduring material.
Objectives - After Attending This Program You Should Be Able To
1. Examine key scientific discoveries in basic science in the field of sexual medicine, explore the underpinning organic factors of sexual function and dysfunction and their interplay with the psycho-social ones in women.
2. Apply principles of patient tailored management and assessment in the context of different cultural settings.
3. Share and explain the efficacy of pharmacological, hormonal, psychological, sex therapy, and physical therapy interventions as part of an integrated approach in female sexual medicine and women's health programs.
ISSWSH Grievance Policy
1. The person with a grievance will first try to informally resolve their grievance by contacting the ISSWSH Executive Office with the issue concerning the meeting, its delivery, the evaluation method, or technological issue.
2. If the aggrieved person is not satisfied with the resolution through informal means, the aggrieved person shall put their grievance in writing to Dr. Parish. Dr. Parish will then consult with appropriate personnel at the organizations that have approved the course to find fair methods of resolving the grievance.
3. If the aggrieved person is not satisfied with the solutions put forth, then they will be directed to put their grievance in writing and contact the appropriate organization, e.g. ISSWSH. Dr. Parish will abide by any decisions regarding resolution of the grievance.
If earlier action steps fail to resolve the problem AASECT should be contacted at
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.
|Graziottin||Alessandra||Alfasigma, Bayer, Gedeon-Richter, Lolipharm, Shionogi, Theramex: Speakers Bureau, Alfasigma, Angelini, Bayer, Fragron, Gedeon-Richter, Lolipharm, Shionogi: Consultant, Alfasigma, Mylan: Scientific/Medical Advisory Board Member|
|Stanley E.||Althof||Nitro-C: Consultant|
|Nicole||Cirino||Sage Therapeutics: Scientific/Medical Advisory Board Member|
|AH||Clayton||Changes in Sexual Functioning Questionnaire, Guilford Publications, Ballantine Books/Random House: Patent Holder, Relmada Therapeutics, Inc, Janssen, Sage Therapeutics: Research Grant Site Principal Investigator, Mediflix LLC, Euthymics and S1 Biopharma: Stock Shareholder, Acadia, Alkermes, Allergan, AMAG Pharmaceuticals, Inc., Astellas, Fabre-Kramer, Ovoca Bio plc, PureTech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, WCG MedAvante-ProPhase: Consultant|
|Brooke||Faught||IPSEN Innovation: Research Grant Site Principal Investigator, Trophikos : Consultant, Therapeutics MD:Speakers Bureau, JDS Therapeutics: Consultant, Lupin: Speakers Bureau|
|W.||Fisher||Social Sciences and Humanities Research Council of Canada: Research Grant Overall Principal Investigator, Canadian Institutes of Health Research: Research Grant Site Principal Investigator|
|Jean Michel||Foidart||MITHRA: Corporate Board Member|
|David||Foster||Solutex Inc.: Research Grant Overall Principal Investigator, Maresins Pharma: Patent Holder|
|Annamaria||Giraldi||Novo Nordic: Stock Shareholder, Eli Lilly: Consultant, Astellas: Speakers Bureau, Palatin Technologies: Scientific/Medical Advisory Board Member, OvacoBio: Scientific/Medical Advisory Board Member, Astellas: Speakers Bureau, Pfizer Inc: Speakers Bureau|
|Irwin||Goldstein||AbbVie: Research Grant Site Principal Investigator, Lipocine: Consultant, Marius: Research Grant Site Principal Investigator, Sprout: Speakers Bureau, TRT: Speakers Bureau|
|Joshua||Gonzalez||Astroglide Lubricants: Consultant, Sprout: Scientific/Medical Advisory Board Member|
|Lyndsey||Harper||Rosy Wellness, Inc: Employee, Rosy Wellness, Inc: Stock Shareholder, Rosy Wellness, Inc: Corporate Board Member|
|Martha||Hickey||Madorra: Research Grant Site Principal Investigator|
|Alyse||Kelly-Jones||Therapeutics MD: Speakers Bureau, Sprout Pharma: Speakers Bureau, Lupin: Consultant, Astellas: Consultan|
|Noel||Kim||Sprout Pharmaceuticals: Consultant, Strategic Science and Technologies: Consultant|
|Choll||Kim||Lumenis: Consultant, Globus Medical: Consultant, Elliquence: Speakers Bureau|
|Sheryl||Kingsberg||Ovoca, Astellas, Mitsubishi Tanaba: Consultant, Endoceutics: Consultant, AMAG Pharmaceuticals, Inc.: Scientific/Medical Advisory Board Member, Palatin Technologies, Inc.: Consultant, Pfizer, Lupin, Materna: Consultant, Dare:Research Grant Site Principal Investigator, dare: Consultant, TherapeuticsMD: Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Emotional Brain:Scientific/Medical Advisory Board Member, Strategic Science Technologies: Consultant|
|Barry||Komisaruk||Apex Neuro: Consultant|
|Andrew||London||Mayne Pharamceutics: Scientific/Medical Advisory Board Member|
|Becky||Lynn||TherapeuticsMD: Speaker, AMAG: Speakers Bureau, Viveve: Speakers Bureau|
|Elizabeth||Mahar||Rosy Wellness, Inc: Consultant|
|Sharon||Parish||AMAG: Writing support, no compensation, Strategic Science Technologies: Consultan|
|Chelsea||Powers||Rosy Wellness: Employee|
|Holly||Rockweiler||Madorra: Stock Shareholder, Madorra: Employee, Madorra: Corporate Board Member, Madorra: Patent Holder|
|Tami||Rowen||TherapeuticsMD: Scientific/Medical Advisory Board Member|
|RS||Rubin||IPSEN: Research Grant Site Principal Investigator, Sprout: Consultant|
|L.||Vignozzi||Received funding from the following companies for scientific research, advisory Board attendance, speaker honoraria: Therascience; Theramex; Bayer-Schering Pharma, Intercept, Lipocine Ibsa:|